- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07816003
Machine Learning Prediction of Spinal Anaesthesia Block Duration
13. september 2026 oppdatert av: SalahEldin Ahmed Abdelaziz Ahmed, Specialized Medical Center (SMC)
Artificial Intelligence-Based Prediction of Sensory and Motor Block Duration Following Spinal Anaesthesia: A Prospective Observational Prediction Model Development Study
The duration of sensory and motor block after spinal anaesthesia varies widely between patients given the same dose of local anaesthetic.
Much of this variability is explained by differences in lumbosacral cerebrospinal fluid volume, which cannot be measured routinely in clinical practice but is related to simple body measurements such as abdominal circumference and vertebral column length.
This prospective observational study will develop and internally validate prediction models for the duration of sensory and motor block following spinal anaesthesia in adults undergoing elective surgery.
Preoperative clinical and anthropometric variables will be recorded, and block regression will be assessed serially after intrathecal injection.
Machine learning methods (lasso regression, ridge regression, random forest, extreme gradient boosting, and support vector regression) will be developed and compared against multivariable linear regression as the reference model.
The aim is a practical tool that helps anaesthetists anticipate how long a spinal block will last in an individual patient, supporting decisions about case scheduling, supplementation, and discharge planning.
Studieoversikt
Status
Har ikke rekruttert ennå
Detaljert beskrivelse
Background.
Spinal anaesthesia produces block of unpredictable duration.
Cerebrospinal fluid volume in the lumbosacral region is the dominant determinant of block spread and regression, and correlates inversely with abdominal circumference and directly with vertebral column length.
Existing single-variable rules perform poorly, and no validated multivariable model is in routine clinical use.
Objectives.
The primary objective is to develop and internally validate models predicting the duration of sensory block and the duration of motor block after single-shot spinal anaesthesia.
The secondary objective is to compare the predictive performance of machine learning approaches with conventional multivariable linear regression.
Design.
Single-centre prospective observational cohort study.
No study-directed intervention is applied; anaesthetic technique, drug, and dose are determined by the attending anaesthetist according to routine practice and are recorded as candidate predictors.
Assessments.
Sensory block level is assessed bilaterally by pinprick with a 25-gauge needle along the mid-clavicular line, over dermatomes T4 to S1. Motor block is assessed using the modified Bromage scale (0-3).
Assessments are performed at fixed intervals from intrathecal injection until complete regression of sensory and motor block.
Candidate predictors.
Age, sex, height, weight, body mass index, abdominal circumference, vertebral column length, ASA physical status, local anaesthetic dose and baricity, and adjuvant use.
Sample size.
A target of 255 participants was derived using the Riley criteria for continuous-outcome prediction models (pmsampsize), assuming 9 candidate predictors, an outcome standard deviation of 40 minutes, anticipated R-squared of 0.35, shrinkage of at least 0.90, and a multiplicative margin of error of 1.10.
The four criteria yielded 183, 183, 234, and 246; the largest requirement of 246 was inflated by approximately 4 per cent for attrition.
Analysis.
Model development will use nested repeated 10-fold cross-validation with bootstrap optimism correction.
Performance will be reported as R-squared, root mean squared error, and mean absolute error, with calibration plots.
SHAP values will be used to describe predictor contributions.
Reporting will follow TRIPOD+AI.
Studietype
Observasjonsmessig
Registrering (Antatt)
255
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiekontakt
- Navn: Salaheldin A Abdelaziz Ahmed
- Telefonnummer: +966508818713
- E-post: saladin28.sa@gmail.com
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
- Eldre voksen
Tar imot friske frivillige
Nei
Prøvetakingsmetode
Ikke-sannsynlighetsprøve
Studiepopulasjon
Consecutive adults scheduled for elective surgery under single-shot spinal anaesthesia at Specialized Medical Center, King Fahad campus, Riyadh.
Beskrivelse
Inclusion Criteria:
- Adults scheduled for elective surgery under single-shot spinal anaesthesia
- ASA physical status I to III
- Written informed consent obtained
Exclusion Criteria:
- Contraindication to neuraxial anaesthesia (coagulopathy, local or systemic infection, raised intracranial pressure, patient refusal)
- Failed or incomplete block requiring conversion to general anaesthesia
- Repeated or top-up intrathecal injection
- Pregnancy
- Known spinal deformity or previous spine surgery
- Pre-existing neurological or neuromuscular disease affecting sensory or motor assessment
- Inability to cooperate with sensory and motor assessment
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Duration of sensory block
Tidsramme: Up to 8 hours after intrathecal injection
|
Time from completion of intrathecal injection to regression of sensory block to the S1 dermatome, assessed bilaterally by pinprick with a 25-gauge needle along the mid-clavicular line
|
Up to 8 hours after intrathecal injection
|
|
Duration of motor block
Tidsramme: Up to 8 hours after intrathecal injection
|
Time from completion of intrathecal injection to return to modified Bromage score 0 (full ability to flex knee and ankle)
|
Up to 8 hours after intrathecal injection
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Predictive performance of machine learning models
Tidsramme: Through study completion, an average of 20 months
|
R-squared, root mean squared error, mean absolute error, and calibration slope for lasso regression, ridge regression, random forest, extreme gradient boosting, and support vector regression, each compared with multivariable linear regression as the reference model
|
Through study completion, an average of 20 months
|
|
Time to peak sensory block level
Tidsramme: Up to 30 minutes after intrathecal injection
|
Time from intrathecal injection to the highest dermatomal level of sensory block, assessed by pinprick
|
Up to 30 minutes after intrathecal injection
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Etterforskere
- Hovedetterforsker: Salaheldin A abdelaziz Ahmed, Specialized Medical Center
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Antatt)
1. desember 2026
Primær fullføring (Antatt)
1. juli 2028
Studiet fullført (Antatt)
1. september 2028
Datoer for studieregistrering
Først innsendt
7. september 2026
Først innsendt som oppfylte QC-kriteriene
7. september 2026
Først lagt ut (Faktiske)
11. september 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
15. september 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
13. september 2026
Sist bekreftet
1. september 2026
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Andre studie-ID-numre
- IRBSMC1-2026-0001
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
JA
IPD-planbeskrivelse
De-identified individual participant data underlying published results, together with the data dictionary and model code, will be made available to researchers whose proposed use has been approved by an independent review committee.
Requests should be directed to the principal investigator.
Data will be available from 6 months to 36 months after publication of the primary results.
IPD-delingstidsramme
Data will become available 6 months after publication of the primary results and will remain available for 36 months
Tilgangskriterier for IPD-deling
Requests should be directed to the principal investigator.
Proposals will be reviewed by the principal investigator and the Specialized Medical Center Institutional Review Board.
Requesters must provide a methodologically sound proposal and sign a data access agreement.
IPD-deling Støtteinformasjonstype
- STUDY_PROTOCOL
- SEVJE
- ICF
- ANALYTIC_CODE
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .